FDA Inspection 813012 — Aspire Independent Review Board LLC
The FDA completed an inspection of Aspire Independent Review Board LLC on December 17, 2012 in Santee, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 17, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Santee, CA (United States)
Additional Details
IRB